• Japanese
  • Korean
  • Chinese
Cover Image

Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Abstract

Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Summary

GlobalData's new report, "Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" provides key market data on the Europe Neurology Devices market - France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Countries covered include France, Germany, Italy, Spain and United Kingdom.
  • Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.
  • Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the market categories and countries.
  • Global corporate-level profiles of key companies operating within the Europe Neurology Devices market..
  • Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Stryker Corporation, Corporation, B. Braun Melsungen AG, Accuray Incorporated, Cadwell Laboratories, Inc. and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Europe Neurology Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

TOC

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 8
  • 1.2 List of Figures 11

2 Introduction 13

  • 2.1 What is This Report About? 13

3 Neurology Devices in Europe 14

  • 3.1 Neurology Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 14
  • 3.2 Neurology Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 16
  • 3.3 Neurology Devices, Europe, Company share (2010-2011) 23

4 Neurology Devices In Germany 25

  • 4.1 Neurology Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 25
  • 4.2 Neurology Devices, Germany, Distribution Share (2010-2011) 31
    • 4.2.1 CSF Management, Germany, Distribution Share (2010-2011) 31
    • 4.2.2 Interventional Neurology, Germany, Distribution Share (2010-2011) 31
    • 4.2.3 Neurological Diagnostic Equipment, Germany, Distribution Share (2010-2011) 32
    • 4.2.4 Neurostimulation Devices, Germany, Distribution Share (2010-2011) 32
    • 4.2.5 Neurosurgical Products, Germany, Distribution Share (2010-2011) 33
    • 4.2.6 Radiosurgery, Germany, Distribution Share (2010-2011) 33
  • 4.3 Neurology Devices, Germany, Company Share (2010-2011) 34
    • 4.3.1 Neurology Devices, Germany, Company Share (2010-2011) 34
    • 4.3.2 CSF Management, Germany, Company Share (2010-2011) 36
    • 4.3.3 Interventional Neurology, Germany, Company Share (2010-2011) 38
    • 4.3.4 Neurological Diagnostic Equipment, Germany, Company Share (2010-2011) 40
    • 4.3.5 Neurostimulation Devices, Germany, Company Share (2010-2011) 42
    • 4.3.6 Neurosurgical Products, Germany, Company Share (2010-2011) 43
    • 4.3.7 Radiosurgery, Germany, Company Share (2010-2011) 44

5 Neurology Devices In France 45

  • 5.1 Neurology Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 45
  • 5.2 Neurology Devices, France, Distribution Share (2010-2011) 51
    • 5.2.1 CSF Management, France, Distribution Share (2010-2011) 51
    • 5.2.2 Interventional Neurology, France, Distribution Share (2010-2011) 51
    • 5.2.3 Neurological Diagnostic Equipment, France, Distribution Share (2010-2011) 52
    • 5.2.4 Neurostimulation Devices, France, Distribution Share (2010-2011) 52
    • 5.2.5 Neurosurgical Products, France, Distribution Share (2010-2011) 53
    • 5.2.6 Radiosurgery, France, Distribution Share (2010-2011) 53
  • 5.3 Neurology Devices, France, Company Share (2010-2011) 54
    • 5.3.1 Neurology Devices, France, Company Share (2010-2011) 54
    • 5.3.2 CSF Management, France, Company Share (2010-2011) 56
    • 5.3.3 Interventional Neurology, France, Company Share (2010-2011) 58
    • 5.3.4 Neurological Diagnostic Equipment, France, Company Share (2010-2011) 60
    • 5.3.5 Neurostimulation Devices, France, Company Share (2010-2011) 62
    • 5.3.6 Neurosurgical Products, France, Company Share (2010-2011) 63
  • 5.4 Radiosurgery, France, Company Share (2010-2011) 64

6 Neurology Devices In United Kingdom 65

  • 6.1 Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 65
  • 6.2 Neurology Devices, United Kingdom, Distribution Share (2010-2011) 71
    • 6.2.1 CSF Management, United Kingdom, Distribution Share (2010-2011) 71
    • 6.2.2 Interventional Neurology, United Kingdom, Distribution Share (2010-2011) 71
    • 6.2.3 Neurological Diagnostic Equipment, United Kingdom, Distribution Share (2010-2011) 72
    • 6.2.4 Neurostimulation Devices, United Kingdom, Distribution Share (2010-2011) 72
    • 6.2.5 Neurosurgical Products, United Kingdom, Distribution Share (2010-2011) 73
    • 6.2.6 Radiosurgery, United Kingdom, Distribution Share (2010-2011) 73
  • 6.3 Neurology Devices, United Kingdom, Company Share (2010-2011) 74
    • 6.3.1 Neurology Devices, United Kingdom, Company Share (2010-2011) 74
    • 6.3.2 CSF Management, United Kingdom, Company Share (2010-2011) 76
    • 6.3.3 Interventional Neurology, United Kingdom, Company Share (2010-2011) 78
    • 6.3.4 Neurological Diagnostic Equipment, United Kingdom, Company Share (2010-2011) 80
    • 6.3.5 Neurostimulation Devices, United Kingdom, Company Share (2010-2011) 82
    • 6.3.6 Neurosurgical Products, United Kingdom, Company Share (2010-2011) 83
    • 6.3.7 Radiosurgery, United Kingdom, Company Share (2010-2011) 84

7 Neurology Devices In Italy 85

  • 7.1 Neurology Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 85
  • 7.2 Neurology Devices, Italy, Distribution Share (2010-2011) 91
    • 7.2.1 CSF Management, Italy, Distribution Share (2010-2011) 91
    • 7.2.2 Interventional Neurology, Italy, Distribution Share (2010-2011) 91
    • 7.2.3 Neurological Diagnostic Equipment, Italy, Distribution Share (2010-2011) 92
    • 7.2.4 Neurostimulation Devices, Italy, Distribution Share (2010-2011) 92
    • 7.2.5 Neurosurgical Products, Italy, Distribution Share (2010-2011) 93
    • 7.2.6 Radiosurgery, Italy, Distribution Share (2010-2011) 93
  • 7.3 Neurology Devices, Italy, Company Share (2010-2011) 94
    • 7.3.1 Neurology Devices, Italy, Company Share (2010-2011) 94
    • 7.3.2 CSF Management, Italy, Company Share (2010-2011) 96
    • 7.3.3 Interventional Neurology, Italy, Company Share (2010-2011) 98
    • 7.3.4 Neurological Diagnostic Equipment, Italy, Company Share (2010-2011) 100
    • 7.3.5 Neurostimulation Devices, Italy, Company Share (2010-2011) 102
    • 7.3.6 Neurosurgical Products, Italy, Company Share (2010-2011) 103
    • 7.3.7 Radiosurgery, Italy, Company Share (2010-2011) 104

8 Neurology Devices In Spain 105

  • 8.1 Neurology Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 105
  • 8.2 Neurology Devices, Spain, Distribution Share (2010-2011) 111
    • 8.2.1 CSF Management, Spain, Distribution Share (2010-2011) 111
    • 8.2.2 Interventional Neurology, Spain, Distribution Share (2010-2011) 111
    • 8.2.3 Neurological Diagnostic Equipment, Spain, Distribution Share (2010-2011) 112
    • 8.2.4 Neurostimulation Devices, Spain, Distribution Share (2010-2011) 112
    • 8.2.5 Neurosurgical Products, Spain, Distribution Share (2010-2011) 113
    • 8.2.6 Radiosurgery, Spain, Distribution Share (2010-2011) 113
  • 8.3 Neurology Devices, Spain, Company Share (2010-2011) 114
    • 8.3.1 Neurology Devices, Spain, Company Share (2010-2011) 114
    • 8.3.2 CSF Management, Spain, Company Share (2010-2011) 116
    • 8.3.3 Interventional Neurology, Spain, Company Share (2010-2011) 118
    • 8.3.4 Neurological Diagnostic Equipment, Spain, Company Share (2010-2011) 120
    • 8.3.5 Neurostimulation Devices, Spain, Company Share (2010-2011) 122
    • 8.3.6 Neurosurgical Products, Spain, Company Share (2010-2011) 123
    • 8.3.7 Radiosurgery, Spain, Company Share (2010-2011) 124

9 Overview of Key Companies in Europe Neurology Devices Market 125

  • 9.1 Medtronic, Inc. 125
    • 9.1.1 Company Overview 125
    • 9.1.2 Share in the Europe Neurology Devices Market 125
  • 9.2 St. Jude Medical, Inc. 126
    • 9.2.1 Company Overview 126
    • 9.2.2 Share in the Europe Neurology Devices Market 126
  • 9.3 Stryker Corporation 127
    • 9.3.1 Company Overview 127
    • 9.3.2 Share in the Europe Neurology Devices Market 127
  • 9.4 Accuray Incorporated 128
    • 9.4.1 Company Overview 128
    • 9.4.2 Share in the Europe Neurology Devices Market 128
  • 9.5 B. Braun Melsungen AG 129
    • 9.5.1 Company Overview 129
    • 9.5.2 Share in the Europe Neurology Devices Market 129
  • 9.6 DePuy, Inc. 130
    • 9.6.1 Company Overview 130
    • 9.6.2 Share in the Europe Neurology Devices Market 130
  • 9.7 Cadwell Laboratories, Inc. 131
    • 9.7.1 Company Overview 131
  • 9.8 Covidien plc 131
    • 9.8.1 Company Overview 131
  • 9.9 Terumo Corporation 131
    • 9.9.1 Company Overview 131
  • 9.10 Cyberonics, Inc. 132
    • 9.10.1 Company Overview 132
  • 9.11 Integra LifeSciences Holdings Corporation 132
    • 9.11.1 Company Overview 132
  • 9.12 CareFusion Corporation 133
    • 9.12.1 Company Overview 133
  • 9.13 Christoph Miethke GmbH & Co. KG 133
    • 9.13.1 Company Overview 133
  • 9.14 Natus Medical Incorporated 134
    • 9.14.1 Company Overview 134
  • 9.15 Micromed S.p.A 134
    • 9.15.1 Company Overview 134
  • 9.16 Boston Scientific Corporation 135
    • 9.16.1 Company Overview 135
  • 9.17 Nihon Kohden Corporation 135
    • 9.17.1 Company Overview 135
  • 9.18 Elekta AB 136
    • 9.18.1 Company Overview 136
  • 9.19 Sophysa S.A. 136
    • 9.19.1 Company Overview 136
  • 9.20 KARL STORZ GmbH & Co. KG 136
    • 9.20.1 Company Overview 136

10 Neurology Devices Market Pipeline Products 137

11 Financial Deals Landscape 141

  • 11.1 Acquisition 141
    • 11.1.1 Elekta Completes Acquisition Of Nucletron For $523 Million 141
  • 11.2 Partnerships 143
    • 11.2.1 Regent Surgical Enters Into Joint Venture Agreement With Hermitage Medical, Neurosurgery Ireland And Accelitech For Neurosurgical Center 143
    • 11.2.2 GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 144

12 Recent Developments 145

  • 12.1 Strategy And Business Planning 145
    • 12.1.1 Feb 09, 2012: Zynex Forms European Subsidiary 145
    • 12.1.2 Dec 19, 2011: Medical Centers Worldwide Adopt Both Accuray's CyberKnife And TomoTherapy Systems 145
    • 12.1.3 Oct 27, 2011: Ambu Announces Organizational Re-Structuring As Part Of Strategy 145
    • 12.1.4 Oct 13, 2011: Unisense Establishes US Headquarter 146
  • 12.2 Research And Development 146
    • 12.2.1 Mar 21, 2012: Index Ventures Launches New €150m Life Sciences Fund With Investments From GSK And Janssen 146
    • 12.2.2 Nov 08, 2011: Bright Light Into Ear Canal Treats Seasonal Depression Effectively In Two Clinical Trials Presented By Valkee And University of Oulu 147
    • 12.2.3 Aug 11, 2011: Valkee And University of Oulu Presents New Findings On Human Brain's Photosensitivity At Scandinavian Physiology Society Annual Meeting 2011 148
  • 12.3 Legal and Regulatory 148
    • 12.3.1 Sep 26, 2011: Occlutech CEO Wins Patent Lawsuit By St Jude-AGA Medical 148
  • 12.4 Government and Public Interest 149
    • 12.4.1 Apr 23, 2012: New Technique May Help Severely Damaged Nerves Regrow And Restore Function: University of Sheffield 149
    • 12.4.2 Feb 18, 2012: New EEG Shows How Brain Tracts Are Formed: Study 149
    • 12.4.3 Jan 27, 2012: Elekta Demonstrates Comprehensive Range Of Cancer Management Solutions At 2012 Arab Health Congress And Exhibition 150
    • 12.4.4 Jan 10, 2012: Fusion Plasma Research Helps Neurologists To Hear Above The Noise 151
    • 12.4.5 Dec 15, 2011: Finland Researchers Develops Decision Support Tool To Help Diagnose Alzheimer's Disease 152
  • 12.5 Product News 153
    • 12.5.1 Sep 26, 2011: Elekta To Showcase Its Products At 2011 ASTRO Meeting In Florida 153

13 Appendix 154

  • 13.1 Definitions of Markets Covered in the Report 155
    • 13.1.1 Neurology Devices 155
  • 13.2 Research Methodology 156
  • 13.3 Secondary Research 156
  • 13.4 Primary Research 157
  • 13.5 Models 157
  • 13.6 Forecasts 157
  • 13.7 Expert Panels 158
  • 13.8 GlobalData Consulting 158
  • 13.9 Currency Conversion 158
  • 13.10 Contact Us 158
  • 13.11 Disclaimer 159

List of Tables

1.1 List of Tables

  • Table 1: Neurology Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 15
  • Table 2: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 17
  • Table 3: Neurology Devices, Europe, Cross-Category Analysis, 2004-2018 18
  • Table 4: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20
  • Table 5: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22
  • Table 6: Neurology Devices, Europe, Company share by Revenue ($m), USD Constant, 2010-2011 24
  • Table 7: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 26
  • Table 8: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 28
  • Table 9: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 30
  • Table 10: CSF Management, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 31
  • Table 11: Interventional Neurology, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 31
  • Table 12: Neurological Diagnostic Equipment, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 32
  • Table 13: Neurostimulation Devices, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 32
  • Table 14: Neurosurgical Products, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 33
  • Table 15: Radiosurgery, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 33
  • Table 16: Neurology Devices, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 35
  • Table 17: CSF Management, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 37
  • Table 18: Interventional Neurology, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 39
  • Table 19: Neurological Diagnostic Equipment, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 41
  • Table 20: Neurostimulation Devices, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 42
  • Table 21: Neurosurgical Products, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 43
  • Table 22: Radiosurgery, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 44
  • Table 23: Neurology Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 46
  • Table 24: Neurology Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 48
  • Table 25: Neurology Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 50
  • Table 26: CSF Management, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 51
  • Table 27: Interventional Neurology, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 51
  • Table 28: Neurological Diagnostic Equipment, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 52
  • Table 29: Neurostimulation Devices, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 52
  • Table 30: Neurosurgical Products, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 53
  • Table 31: Radiosurgery, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 53
  • Table 32: Neurology Devices, France, Company Share, USD Constant, (2010-2011) 55
  • Table 33: CSF Management, France, Company Share by Revenue ($m), USD Constant, 2010-2011 57
  • Table 34: Interventional Neurology, France, Company Share by Revenue ($m), USD Constant, 2010-2011 59
  • Table 35: Neurological Diagnostic Equipment, France, Company Share by Revenue ($m), USD Constant, 2010-2011 61
  • Table 36: Neurostimulation Devices, France, Company Share by Revenue ($m), USD Constant, 2010-2011 62
  • Table 37: Neurosurgical Products, France, Company Share by Revenue ($m), USD Constant, 2010-2011 63
  • Table 38: Radiosurgery, France, Company Share by Revenue ($m), USD Constant, 2010-2011 64
  • Table 39: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 66
  • Table 40: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 68
  • Table 41: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 70
  • Table 42: CSF Management, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71
  • Table 43: Interventional Neurology, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71
  • Table 44: Neurological Diagnostic Equipment, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 72
  • Table 45: Neurostimulation Devices, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 72
  • Table 46: Neurosurgical Products, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 73
  • Table 47: Radiosurgery, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 73
  • Table 48: Neurology Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 75
  • Table 49: CSF Management, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 77
  • Table 50: Interventional Neurology, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 79
  • Table 51: Neurological Diagnostic Equipment, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 81
  • Table 52: Neurostimulation Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 82
  • Table 53: Neurosurgical Products, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 83
  • Table 54: Radiosurgery, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 84
  • Table 55: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 86
  • Table 56: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011 88
  • Table 57: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 90
  • Table 58: CSF Management, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 91
  • Table 59: Interventional Neurology, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 91
  • Table 60: Neurological Diagnostic Equipment, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 92
  • Table 61: Neurostimulation Devices, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 92
  • Table 62: Neurosurgical Products, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 93
  • Table 63: Radiosurgery, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 93
  • Table 64: Neurology Devices, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 95
  • Table 65: CSF Management, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 97
  • Table 66: Interventional Neurology, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 99
  • Table 67: Neurological Diagnostic Equipment, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 101
  • Table 68: Neurostimulation Devices, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 102
  • Table 69: Neurosurgical Products, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 103
  • Table 70: Radiosurgery, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 104
  • Table 71: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 106
  • Table 72: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 108
  • Table 73: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 110
  • Table 74: CSF Management, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 111
  • Table 75: Interventional Neurology, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 111
  • Table 76: Neurological Diagnostic Equipment, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 112
  • Table 77: Neurostimulation Devices, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 112
  • Table 78: Neurosurgical Products, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 113
  • Table 79: Radiosurgery, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 113
  • Table 80: Neurology Devices, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 115
  • Table 81: CSF Management, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 117
  • Table 82: Interventional Neurology, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 119
  • Table 83: Neurological Diagnostic Equipment, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 121
  • Table 84: Neurostimulation Devices, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 122
  • Table 85: Neurosurgical Products, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 123
  • Table 86: Radiosurgery, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 124
  • Table 87: Neurology Devices Market Pipeline Products 137
  • Table 88: Elekta Completes Acquisition Of Nucletron For $523 Million 141
  • Table 89: Regent Surgical Enters Into Joint Venture Agreement With Hermitage Medical, Neurosurgery Ireland And Accelitech For Neurosurgical Center 143
  • Table 90: GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 144

List of Figures

1.2 List of Figures

  • Figure 1: Neurology Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 14
  • Figure 2: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 16
  • Figure 3: Neurology Devices, Europe, Cross-Category Analysis, 2004-2018 18
  • Figure 4: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19
  • Figure 5: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 21
  • Figure 6: Neurology Devices, Europe, Company share (%), 2011 23
  • Figure 7: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 25
  • Figure 8: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 27
  • Figure 9: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 29
  • Figure 10: Neurology Devices, Germany, Company Share (%), 2011 34
  • Figure 11: CSF Management, Germany, Company Share (%), 2011 36
  • Figure 12: Interventional Neurology, Germany, Company Share (%), 2011 38
  • Figure 13: Neurological Diagnostic Equipment, Germany, Company Share (%), 2011 40
  • Figure 14: Neurostimulation Devices, Germany, Company Share (%), 2011 42
  • Figure 15: Neurosurgical Products, Germany, Company Share (%), 2011 43
  • Figure 16: Neurology Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 45
  • Figure 17: Neurology Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 47
  • Figure 18: Neurology Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 49
  • Figure 19: Neurology Devices, France, Company Share (%), 2011 54
  • Figure 20: CSF Management, France, Company Share (%), 2011 56
  • Figure 21: Interventional Neurology, France, Company Share (%), 2011 58
  • Figure 22: Neurological Diagnostic Equipment, France, Company Share (%), 2011 60
  • Figure 23: Neurostimulation Devices, France, Company Share (%), 2011 62
  • Figure 24: Neurosurgical Products, France, Company Share (%), 2011 63
  • Figure 25: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 65
  • Figure 26: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 67
  • Figure 27: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 69
  • Figure 28: Neurology Devices, United Kingdom, Company Share (%), 2011 74
  • Figure 29: CSF Management, United Kingdom, Company Share (%), 2011 76
  • Figure 30: Interventional Neurology, United Kingdom, Company Share (%), 2011 78
  • Figure 31: Neurological Diagnostic Equipment, United Kingdom, Company Share (%), 2011 80
  • Figure 32: Neurostimulation Devices, United Kingdom, Company Share (%), 2011 82
  • Figure 33: Neurosurgical Products, United Kingdom, Company Share (%), 2011 83
  • Figure 34: Radiosurgery, United Kingdom, Company Share (%), 2011 84
  • Figure 35: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 85
  • Figure 36: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011 87
  • Figure 37: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 89
  • Figure 38: Neurology Devices, Italy, Company Share (%), 2011 94
  • Figure 39: CSF Management, Italy, Company Share (%), 2011 96
  • Figure 40: Interventional Neurology, Italy, Company Share (%), 2011 98
  • Figure 41: Neurological Diagnostic Equipment, Italy, Company Share (%), 2011 100
  • Figure 42: Neurostimulation Devices, Italy, Company Share (%), 2011 102
  • Figure 43: Neurosurgical Products, Italy, Company Share (%), 2011 103
  • Figure 44: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 105
  • Figure 45: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 107
  • Figure 46: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 109
  • Figure 47: Neurology Devices, Spain, Company Share (%), 2011 114
  • Figure 48: CSF Management, Spain, Company Share (%), 2011 116
  • Figure 49: Interventional Neurology, Spain, Company Share (%), 2011 118
  • Figure 50: Neurological Diagnostic Equipment, Spain, Company Share (%), 2011 120
  • Figure 51: Neurostimulation Devices, Spain, Company Share (%), 2011 122
  • Figure 52: Neurosurgical Products, Spain, Company Share (%), 2011 123
  • Figure 53: Medtronic, Inc., Company Share (%), Europe Neurology Devices Market, 2011 125
  • Figure 54: St. Jude Medical, Inc., Company Share (%), Europe Neurology Devices Market, 2011 126
  • Figure 55: Stryker Corporation, Company Share (%), Europe Neurology Devices Market, 2011 127
  • Figure 56: Accuray Incorporated, Company Share (%), Europe Neurology Devices Market, 2011 128
  • Figure 57: B. Braun Melsungen AG, Company Share (%), Europe Neurology Devices Market, 2011 129
  • Figure 58: DePuy, Inc., Company Share (%), Europe Neurology Devices Market, 2011 130
Show More
Pricing